Investor Relations

Investor Overview

Webcast ImageWebcast
KemPharm Inc at the Oppenheimer & Co. 27th Annual Healthcare Conference (Replay)
03/21/17 at 9:45 a.m. ET
KemPharm Inc at the Oppenheimer & Co. 27th Annual Healthcare Conference
Tuesday, March 21, 2017 9:45 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

KemPharm uses its LAT platform technology to discover and develop prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability and safety.

 

Stock Quote
KMPH (Common Stock)
PriceChange% ChangeVolume
$4.25 + 0.102.41%25,963
Previous CloseToday's OpenIntraday HighIntraday Low
$4.15$4.15$4.25$4.15
Exchange: NASDAQ (US Dollar)
03/23/17 3:59 p.m. ET
Refresh quote
Recent NewsMore >>
03/16/17
KemPharm Presents Clinical Data for Opioid Prodrug Candidates at American Academy of Pain Medicine’s Annual Meeting
03/09/17
KemPharm, Inc. Reports Fourth Quarter and Year End 2016 Results
02/28/17
KemPharm, Inc. to Report Fourth Quarter and Year End 2016 Results
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources